26 May 2013
Keywords: adx48621, enters, ph, testing, geneva, switzerland-based, drugmaker
Article | 16 April 2007
Geneva, Switzerland-based drugmaker Addex Pharma has initiated a Phase I study of ADX48621, a compound with a novel mechanism of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 2007
24 May 2013
© 2013 thepharmaletter.com